Growth Opportunity Target expanding R&D footprint and planned headquarters expansion in Providence as indicators of increasing capacity and demand for EGM solutions, presenting an opportunity to upsell platform licenses, service packages, and ongoing support.

Hematologic Focus Recent news highlights collaboration and development of Electronic Genome Mapping applications for hematologic malignancies, suggesting a strong use case and potential for targeted outreach to oncology and hematology customers with SV and CNV analysis needs.

End-to-End Platform OhmX platform features a compact, easy-to-operate, end-to-end workflow with accessible analytics, presenting a compelling value proposition for labs seeking streamlined SV analysis and reduced hands-on time, ideal for sales pitches around total solution adoption.

High-Resolution Value Capability to detect SVs as small as 300 bp with long read lengths and high-density mapping offers a competitive edge over traditional methods, enabling conversations about improved diagnostic yield and potential integration with existing sequencing pipelines.

Strategic Partnerships Multi-year collaborations with academic institutions and planned industry presentations indicate a momentum and credibility that can be leveraged to engage research labs, hospitals, and biotech firms in co-development or pilot programs.